Ceftizoxime

Revision as of 03:36, 31 December 2013 by Gerald Chi (talk | contribs) (Changed protection level for "Ceftizoxime" ([Edit=Allow only autoconfirmed users] (expires 03:36, 14 January 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 03:36, 14 January 2014 (UTC))))
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Ceftizoxime is a third-generation cephalosporin available for parenteral administration.

Unlike other 3rd generation cephalosporins, in ceftizoxime the whole C-3 side chain has been removed to prevent deactivation by hydrolytic enzymes. It rather resembles cefotaxime in its properties, but is not subjected to metabolism.

Category

US Brand Names

CEFIZOX

FDA Package Insert

Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility, Reconstitution, and Stability | Directions For Use | How Supplied | Labels and Packages

Mechanism of Action

References